<VariationArchive VariationID="13801" VariationName="NM_000278.5(PAX2):c.76del (p.Val26fs)" VariationType="Deletion" Accession="VCV000013801" Version="7" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-06-23" DateCreated="2013-04-04" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="28840" VariationID="13801">
      <GeneList>
        <Gene Symbol="PAX2" FullName="paired box 2" GeneID="5076" HGNC_ID="HGNC:8616" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q24.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="100735396" stop="100829944" display_start="100735396" display_stop="100829944" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="102505467" stop="102589697" display_start="102505467" display_stop="102589697" Strand="+" />
          </Location>
          <OMIM>167409</OMIM>
          <Haploinsufficiency last_evaluated="2020-02-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-02-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000278.5(PAX2):c.76del (p.Val26fs)</Name>
      <CanonicalSPDI>NC_000010.11:100749771:GGGGGGG:GGGGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10q24.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="100749772" stop="100749772" display_start="100749772" display_stop="100749772" variantLength="1" positionVCF="100749771" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="102509529" stop="102509529" display_start="102509529" display_stop="102509529" variantLength="1" positionVCF="102509528" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>V26fs</ProteinChange>
      <ProteinChange>V57fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.102509535del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.102509535del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.100749778del" Assembly="GRCh38">
            <Expression>NC_000010.11:g.100749778del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008680.2" sequenceAccession="NG_008680" sequenceVersion="2" change="g.19070del">
            <Expression>NG_008680.2:g.19070del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000278.5" sequenceAccession="NM_000278" sequenceVersion="5" change="c.76del" MANESelect="true">
            <Expression>NM_000278.5:c.76del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000269.3" sequenceAccession="NP_000269" sequenceVersion="3" change="p.Val26fs">
            <Expression>NP_000269.3:p.Val26fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001304569.2" sequenceAccession="NM_001304569" sequenceVersion="2" change="c.169del">
            <Expression>NM_001304569.2:c.169del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001291498.1" sequenceAccession="NP_001291498" sequenceVersion="1" change="p.Val57fs">
            <Expression>NP_001291498.1:p.Val57fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003987.5" sequenceAccession="NM_003987" sequenceVersion="5" change="c.76del">
            <Expression>NM_003987.5:c.76del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003978.3" sequenceAccession="NP_003978" sequenceVersion="3" change="p.Val26fs">
            <Expression>NP_003978.3:p.Val26fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003988.5" sequenceAccession="NM_003988" sequenceVersion="5" change="c.76del">
            <Expression>NM_003988.5:c.76del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003979.2" sequenceAccession="NP_003979" sequenceVersion="2" change="p.Val26fs">
            <Expression>NP_003979.2:p.Val26fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003989.5" sequenceAccession="NM_003989" sequenceVersion="5" change="c.76del">
            <Expression>NM_003989.5:c.76del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003980.3" sequenceAccession="NP_003980" sequenceVersion="3" change="p.Val26fs">
            <Expression>NP_003980.3:p.Val26fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003990.5" sequenceAccession="NM_003990" sequenceVersion="5" change="c.76del">
            <Expression>NM_003990.5:c.76del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003981.3" sequenceAccession="NP_003981" sequenceVersion="3" change="p.Val26fs">
            <Expression>NP_003981.3:p.Val26fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA256974" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="167409.0008" DB="OMIM" />
        <XRef Type="rs" ID="75462234" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000278.5(PAX2):c.76del (p.Val26fs) AND Renal coloboma syndrome" Accession="RCV000014812" Version="31">
        <ClassifiedConditionList TraitSetID="3806">
          <ClassifiedCondition DB="MedGen" ID="C1852759">Renal coloboma syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-07-14" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000278.5(PAX2):c.76del (p.Val26fs) AND multiple conditions" Accession="RCV002504787" Version="3">
        <ClassifiedConditionList TraitSetID="26560">
          <ClassifiedCondition DB="MedGen" ID="C4014925">Focal segmental glomerulosclerosis 7</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1852759">Renal coloboma syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-07-15" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000278.5(PAX2):c.76del (p.Val26fs) AND PAX2-related disorder" Accession="RCV003389233" Version="1">
        <ClassifiedConditionList TraitSetID="70296">
          <ClassifiedCondition>PAX2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-13" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2013-04-04" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10466411</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10533062</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11461952</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21108633</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22213154</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24676634</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27657687</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28566479</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32203253</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">36549658</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3806" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3472" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">RENAL-COLOBOMA SYNDROME WITH MACULAR ABNORMALITIES</ElementValue>
                <XRef Type="MIM" ID="120330" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CONGENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT WITH OR WITHOUT OCULAR ABNORMALITIES</ElementValue>
                <XRef Type="MIM" ID="120330" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CAKUT WITH OR WITHOUT OCULAR ABNORMALITIES</ElementValue>
                <XRef Type="MIM" ID="120330" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Papillorenal syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PAPILLORENAL SYNDROME WITH MILD OCULAR ABNORMALITIES</ElementValue>
                <XRef Type="Allelic variant" ID="167409.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="167409.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Renal coloboma syndrome</ElementValue>
                <XRef ID="Papillorenal+syndrome/5572" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007352" DB="MONDO" />
                <XRef ID="446449009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic nerve coloboma with renal disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic coloboma, vesicoureteral reflux, and renal anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Coloboma of optic nerve with renal disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PAPRS</ElementValue>
                <XRef Type="MIM" ID="120330" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PAX2-related disorder is an autosomal dominant disorder associated with renal and eye abnormalities. The disorder was originally referred to as renal coloboma syndrome and characterized by renal hypodysplasia and abnormalities of the optic nerve; with improved access to molecular testing, a wider range of phenotypes has been recognized in association with pathogenic variants in PAX2. Abnormal renal structure or function is noted in 92% of affected individuals and ophthalmologic abnormalities in 77% of affected individuals. Renal abnormalities can be clinically silent in rare individuals. In most individuals, clinically significant renal insufficiency / renal failure is reported. End-stage renal disease requiring renal transplant is not uncommon. Uric acid nephrolithiasis has been reported. Ophthalmologic abnormalities are typically described as optic nerve coloboma or dysplasia. Iris colobomas have not been reported in any individual with PAX2–related disorder. Ophthalmologic abnormalities may significantly impair vision in some individuals, while others have subtle changes only noted after detailed ophthalmologic examination. Additional clinical findings include high-frequency sensorineural hearing loss, soft skin, and ligamentous laxity. PAX2 pathogenic variants have been identified in multiple sporadic and familial cases of nonsyndromic renal disease including renal hypodysplasia and focal segmental glomerulosclerosis.</Attribute>
                <XRef ID="NBK1451" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4106" />
                <XRef ID="4106" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301624</ID>
                <ID Source="BookShelf">NBK1451</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21326282</ID>
              </Citation>
              <XRef ID="1475" DB="Orphanet" />
              <XRef ID="C1852759" DB="MedGen" />
              <XRef ID="MONDO:0007352" DB="MONDO" />
              <XRef Type="MIM" ID="120330" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="70296" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="57561" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">PAX2-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="26560" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3472" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">RENAL-COLOBOMA SYNDROME WITH MACULAR ABNORMALITIES</ElementValue>
                <XRef Type="MIM" ID="120330" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CONGENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT WITH OR WITHOUT OCULAR ABNORMALITIES</ElementValue>
                <XRef Type="MIM" ID="120330" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CAKUT WITH OR WITHOUT OCULAR ABNORMALITIES</ElementValue>
                <XRef Type="MIM" ID="120330" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Papillorenal syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PAPILLORENAL SYNDROME WITH MILD OCULAR ABNORMALITIES</ElementValue>
                <XRef Type="Allelic variant" ID="167409.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="167409.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Renal coloboma syndrome</ElementValue>
                <XRef ID="Papillorenal+syndrome/5572" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007352" DB="MONDO" />
                <XRef ID="446449009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic nerve coloboma with renal disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic coloboma, vesicoureteral reflux, and renal anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Coloboma of optic nerve with renal disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PAPRS</ElementValue>
                <XRef Type="MIM" ID="120330" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PAX2-related disorder is an autosomal dominant disorder associated with renal and eye abnormalities. The disorder was originally referred to as renal coloboma syndrome and characterized by renal hypodysplasia and abnormalities of the optic nerve; with improved access to molecular testing, a wider range of phenotypes has been recognized in association with pathogenic variants in PAX2. Abnormal renal structure or function is noted in 92% of affected individuals and ophthalmologic abnormalities in 77% of affected individuals. Renal abnormalities can be clinically silent in rare individuals. In most individuals, clinically significant renal insufficiency / renal failure is reported. End-stage renal disease requiring renal transplant is not uncommon. Uric acid nephrolithiasis has been reported. Ophthalmologic abnormalities are typically described as optic nerve coloboma or dysplasia. Iris colobomas have not been reported in any individual with PAX2–related disorder. Ophthalmologic abnormalities may significantly impair vision in some individuals, while others have subtle changes only noted after detailed ophthalmologic examination. Additional clinical findings include high-frequency sensorineural hearing loss, soft skin, and ligamentous laxity. PAX2 pathogenic variants have been identified in multiple sporadic and familial cases of nonsyndromic renal disease including renal hypodysplasia and focal segmental glomerulosclerosis.</Attribute>
                <XRef ID="NBK1451" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4106" />
                <XRef ID="4106" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301624</ID>
                <ID Source="BookShelf">NBK1451</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21326282</ID>
              </Citation>
              <XRef ID="1475" DB="Orphanet" />
              <XRef ID="C1852759" DB="MedGen" />
              <XRef ID="MONDO:0007352" DB="MONDO" />
              <XRef Type="MIM" ID="120330" DB="OMIM" />
            </Trait>
            <Trait ID="31865" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Focal segmental glomerulosclerosis 7</ElementValue>
                <XRef ID="MONDO:0014451" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FSGS7</ElementValue>
                <XRef Type="MIM" ID="616002" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16045" />
                <XRef ID="16045" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="656" DB="Orphanet" />
              <XRef ID="C4014925" DB="MedGen" />
              <XRef ID="MONDO:0014451" DB="MONDO" />
              <XRef Type="MIM" ID="616002" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="35067" SubmissionDate="2013-01-08" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="167409.0008_PAPILLORENAL SYNDROME" title="PAX2, 1-BP DEL, G, EX2_PAPILLORENAL SYNDROME" />
        <ClinVarAccession Accession="SCV000035067" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Caucasian mother and daughter, aged 33 and 5 years, respectively, Schimmenti et al. (1999) identified a 1-bp deletion that resulted in a homoguanine tract from 7 G's to 6 G's in one allele of PAX2. The daughter, the proband, presented to clinic with bilateral optic nerve colobomas and a history of vesicoureteral reflux. Optic nerve colobomas had been discovered during an evaluation for nystagmus and esotropia. She had some limitation of vision. Several urinary tract infections led to the demonstration of vesicoureteral reflux. She had bilateral fourth and fifth digit clinodactyly. The mother had bilateral optic nerve colobomas and a history of urinary tract infections. Renal cysts were identified during childhood by intravenous pyelogram. Diagnosis of bilateral optic nerve colobomas was made incidentally after an eye injury at age 4. Visual acuity was only mildly affected.</Attribute>
              <Citation>
                <ID Source="PubMed">10533062</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Based on nucleotide numbering reflecting the cDNA transcript with +1 corresponding to the A of the ATG translation initiation codon in the reference sequence, Bower et al. (2012) referred to the 619delG mutation as 76del, and to the predicted effect on the protein as Val26Cysfs*3.</Attribute>
              <Citation>
                <ID Source="PubMed">22213154</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAX2" />
          </GeneList>
          <Name>PAX2, 1-BP DEL, G, EX2</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, G, EX2</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="167409.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PAPILLORENAL SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="497873" SubmissionDate="2016-01-11" DateLastUpdated="2015-10-11" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="PAX2_c.70delG|OMIM:120330" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000265639" DateUpdated="2015-10-11" DateCreated="2015-10-11" Type="SCV" Version="1" SubmitterName="Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine" OrgID="505572" OrganizationCategory="laboratory" OrgAbbreviation="BHCMG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">27657687</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Bekheirnia et al. (Genet Med. 2016)</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">27657687</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1">
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
            </Sample>
            <Method>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Renal dysplasia</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003990.3:c.76delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="120330" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">27657687</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27657687</ID>
        </Citation>
        <StudyDescription>Monoallelic SNVs and CNVs identified from WES studies of a cohort of patients with CAKUT. SNVs in both known genes and novel genes were reported.</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>Bekheirnia_CAKUT_2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5456677" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_003987.5:c.76del|OMIM:120330;616002" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002810465" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003987.5:c.76del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="120330" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616002" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6150252" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="5886224|MedGen:C1852759;C4014925" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003460068" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27657687</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28566479</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11461952</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24676634</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 13801). This variant is also known as c.70delG (p.G24fs). This premature translational stop signal has been observed in individual(s) with clinical features of PAX2-related conditions (PMID: 27657687, 28566479). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val26Cysfs*3) in the PAX2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PAX2 are known to be pathogenic (PMID: 11461952, 24676634).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.102509529del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1852759" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4014925" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4940215" SubmissionDate="2022-05-28" DateLastUpdated="2022-06-03" DateCreated="2022-06-03">
        <ClinVarSubmissionID localKey="10-102509528-CG-C" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002521121" DateUpdated="2022-06-03" DateCreated="2022-06-03" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10466411</ID>
          </Citation>
          <Comment>The variant is not observed in the gnomAD v2.1.1 dataset. Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000013801 / PMID: 10466411). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000107" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000089" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000278.5:c.76del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="120330" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11507599</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7569495" SubmissionDate="2023-10-19" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="172-20230924" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV004045811" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München" OrgID="500240" OrganizationCategory="clinic" OrgAbbreviation="IHG-MRI-TUM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Classification criteria August 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/inodbbrd/classification_criteria.pdf</URL>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0012582" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0025195" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001744" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="C" referenceAllele="CG" start="102509528" stop="102509529" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="120330" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023-09-24</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7680921" SubmissionDate="2023-11-06" DateLastUpdated="2023-11-11" DateCreated="2023-11-11">
        <ClinVarSubmissionID localKey=":Chr.10_102509528_CG_C|PAX2-related disorder" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004101317" DateUpdated="2023-11-11" DateCreated="2023-11-11" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32203253</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">36549658</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28566479</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21108633</ID>
          </Citation>
          <Comment>The PAX2 c.76del (p.Val26CysfsTer3) variant causes a shift in the protein reading frame that is predicted to result in premature termination of the protein. Loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay is expected. The p.Val26CysfsTer3 variant has been reported in a heterozygous state in at least six individuals with chronic kidney disease, renal malformations, and variable ocular phenotypes. The variant was confirmed de novo in three of these individuals and inherited from an affected parent in one individual (PMID: 21108633; 28566479; 32203253; 36549658). This variant is not observed in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. This variant was identified in a de novo state. Based on the available evidence, the c.76del (p.Val26CysfsTer3) variant is classified as pathogenic for PAX2-related disorder.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSLVariantClassificationCriteria RUGD 01 April 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/dy7elfgy/icslvariantclassificationcriteria_rugd_01_april_2020.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="C" referenceAllele="CG" start="102509528" stop="102509529" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PAX2-related disorder</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13955340</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7680921" TraitType="Disease" MappingType="Name" MappingValue="PAX2-related disorder" MappingRef="Preferred">
        <MedGen CUI="None" Name="PAX2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="497873" TraitType="Disease" MappingType="XRef" MappingValue="120330" MappingRef="OMIM">
        <MedGen CUI="C1852759" Name="Renal coloboma syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569495" TraitType="Disease" MappingType="XRef" MappingValue="HP:0012582" MappingRef="HP">
        <MedGen CUI="C0431698" Name="Bilateral renal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569495" TraitType="Disease" MappingType="XRef" MappingValue="HP:0025195" MappingRef="HP">
        <MedGen CUI="C4476646" Name="Central diaphragmatic hernia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6150252" TraitType="Disease" MappingType="XRef" MappingValue="C1852759" MappingRef="MedGen">
        <MedGen CUI="C1852759" Name="Renal coloboma syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940215" TraitType="Disease" MappingType="XRef" MappingValue="120330" MappingRef="OMIM">
        <MedGen CUI="C1852759" Name="Renal coloboma syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="497873" TraitType="Finding" MappingType="Name" MappingValue="Renal dysplasia" MappingRef="Preferred">
        <MedGen CUI="C3536714" Name="Renal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569495" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001744" MappingRef="HP">
        <MedGen CUI="C0038002" Name="Splenomegaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940215" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000107" MappingRef="HP">
        <MedGen CUI="C3887499" Name="Renal cyst" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="35067" TraitType="Disease" MappingType="Name" MappingValue="PAPILLORENAL SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C1852759" Name="Renal coloboma syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940215" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000089" MappingRef="HP">
        <MedGen CUI="C0266295" Name="Renal hypoplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5456677" TraitType="Disease" MappingType="XRef" MappingValue="616002" MappingRef="OMIM">
        <MedGen CUI="C4014925" Name="Focal segmental glomerulosclerosis 7" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6150252" TraitType="Disease" MappingType="XRef" MappingValue="C4014925" MappingRef="MedGen">
        <MedGen CUI="C4014925" Name="Focal segmental glomerulosclerosis 7" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569495" TraitType="Disease" MappingType="XRef" MappingValue="120330" MappingRef="OMIM">
        <MedGen CUI="C1852759" Name="Renal coloboma syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5456677" TraitType="Disease" MappingType="XRef" MappingValue="120330" MappingRef="OMIM">
        <MedGen CUI="C1852759" Name="Renal coloboma syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

